Pressmeddelanden, rapporter och bolagsmeddelande för Dancann Pharma
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Market Notices: Market Notice 187/21– Last day of trading in DanCann Pharma A/S’s subscription option DANCAN TO 1
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Tetra Bio-Pharma Receives Positive Scientific Advice Assessment (SAA) Report for QIXLEEF™
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S informs about warrants of series TO1
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S publishes Q2-2021 report
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S has reached a historic milestone with the first ever cannabis batch in BIOTECH PHARM1
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S’ CEO and CCO have subscribed for shares and warrants in the directed issue
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S has carried out a directed issue of shares of approx. DKK 6.375 million and warrants, in combination with obtaining a loan facility of SEK 13.7 million
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: Minutes from Extraordinary General Meeting in DanCann Pharma A/S
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Tetra Bio-Pharma Accelerates REBORN1© Trial
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: The Board of Directors of DanCann Pharma A/S convenes an Extraordinary General Meeting and proposes that the Meeting resolves a directed share issue